PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $195,000 | -61.2% | 62,163 | -54.0% | 0.00% | -63.6% |
| Q1 2019 | $502,000 | +28.1% | 135,008 | 0.0% | 0.01% | +10.0% |
| Q4 2018 | $392,000 | +1.8% | 135,008 | -7.8% | 0.01% | +25.0% |
| Q3 2018 | $385,000 | +12.2% | 146,408 | 0.0% | 0.01% | +14.3% |
| Q2 2018 | $343,000 | -24.6% | 146,408 | -5.3% | 0.01% | -22.2% |
| Q1 2018 | $455,000 | +7.3% | 154,666 | 0.0% | 0.01% | +12.5% |
| Q4 2017 | $424,000 | -19.1% | 154,666 | 0.0% | 0.01% | -33.3% |
| Q3 2017 | $524,000 | +34.0% | 154,666 | -2.3% | 0.01% | +50.0% |
| Q2 2017 | $391,000 | +8.9% | 158,266 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $359,000 | 0.0% | 158,266 | -6.5% | 0.01% | 0.0% |
| Q4 2016 | $359,000 | -37.2% | 169,342 | -0.9% | 0.01% | -33.3% |
| Q3 2016 | $572,000 | -68.4% | 170,822 | -29.4% | 0.01% | -58.6% |
| Q3 2015 | $1,808,000 | 0.0% | 242,091 | 0.0% | 0.03% | +3.6% |
| Q3 2014 | $1,808,000 | – | 242,091 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |